OASIS PHARMACEUTICALS, LLC STTR Phase I Award, September 2021
A STTR Phase I contract was awarded to OASIS PHARMACEUTICALS, LLC in September, 2021 for $361,774.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.